These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21577272)

  • 41. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acupuncture for paroxysmal and persistent atrial fibrillation: An effective non-pharmacological tool?
    Lombardi F; Belletti S; Battezzati PM; Lomuscio A
    World J Cardiol; 2012 Mar; 4(3):60-5. PubMed ID: 22451853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future.
    Heijman J; Hohnloser SH; Camm AJ
    Europace; 2021 Apr; 23(23 Suppl 2):ii14-ii22. PubMed ID: 33837753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmaceutical pipeline for atrial fibrillation.
    Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
    Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure.
    Beliaeva MM; Dzaurova KM; Yuricheva YA; Novikov PS; Mironov NY; Tarasovskiy GS; Zelberg MA; Sokolov SF; Golitsyn SP
    J Cardiovasc Dev Dis; 2023 Dec; 10(12):. PubMed ID: 38132655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Relationship between efficacy of antiarrhythmic drug therapy and structural remodeling in patients with paroxysmal atrial fibrillation].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Okumura K
    J Cardiol; 2005 Dec; 46(6):229-36. PubMed ID: 16389742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
    Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms and Drug Development in Atrial Fibrillation.
    Calvo D; Filgueiras-Rama D; Jalife J
    Pharmacol Rev; 2018 Jul; 70(3):505-525. PubMed ID: 29921647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of the older person with atrial fibrillation.
    Aronow WS
    J Am Geriatr Soc; 1999 Jun; 47(6):740-8. PubMed ID: 10366178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
    Piccini JP; Pritchett EL; Davison BA; Cotter G; Wiener LE; Koch G; Feld G; Waldo A; van Gelder IC; Camm AJ; Kowey PR; Iwashita J; Dittrich HC
    Heart Rhythm; 2016 Sep; 13(9):1777-83. PubMed ID: 27108936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonpharmacologic strategies for treating atrial fibrillation.
    Lüderitz B; Pfeiffer D; Tebbenjohanns J; Jung W
    Am J Cardiol; 1996 Jan; 77(3):45A-52A. PubMed ID: 8607391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. European multicentre experience of staged hybrid atrial fibrillation ablation for the treatment of persistent and longstanding persistent atrial fibrillation.
    Haywood GA; Varini R; Osmancik P; Cireddu M; Caldwell J; Chaudhry MA; Loubani M; Della Bella P; Lapenna E; Budera P; Dalrymple-Hay M
    Int J Cardiol Heart Vasc; 2020 Feb; 26():100459. PubMed ID: 32140550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Current antiarrhythmic drug therapy in atrial fibrillation].
    Goette A
    Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S33-7. PubMed ID: 20221976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
    Macchia A; Grancelli H; Varini S; Nul D; Laffaye N; Mariani J; Ferrante D; Badra R; Figal J; Ramos S; Tognoni G; Doval HC;
    J Am Coll Cardiol; 2013 Jan; 61(4):463-468. PubMed ID: 23265344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugida F; Nakamura M
    Int Heart J; 2010 Mar; 51(2):98-104. PubMed ID: 20379042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
    Schilling RJ
    Heart; 2010 Mar; 96(5):333-8. PubMed ID: 19910286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.